CNBC's Herb Greenberg reports on recent action in shares of Molycorp since Morgan Stanley's "overweight" rating, and Dahlman & Rose's "hold" rating on the stock.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT